Jasper Ridge Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-60,196
Closed -$2.58M 83
2017
Q3
$2.58M Buy
+60,196
New +$1.92M 0.13% 35
2017
Q2
Sell
-25,686
Closed -$338K 95
2017
Q1
$338K Buy
+25,686
New +$329K 0.02% 81

Other funds holding MYOK

Jasper Ridge Partners's MYOK Position: Q4 2017 in Review

Jasper Ridge Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 60,196 shares — an estimated $2.58M sold.

Jasper Ridge Partners first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $2.58M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Jasper Ridge Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Jasper Ridge Partners sold 60,196 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $2.58M.
  • Jasper Ridge Partners first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Jasper Ridge Partners's MyoKardia, Inc. Common Stock position peaked at $2.58M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Jasper Ridge Partners's 13F filing for Q4 2017, filed 14 Feb 2018.